Umber Saleem

Umber Saleem is a researcher at the Institute of Experimental Pharmacology and Toxicology within the Faculty of Medicine at University Medical Center Hamburg-Eppendorf. Their work focuses on cardiac physiology, stem cell-derived cardiomyocyte models, and cardiovascular disease mechanisms.

Research interests span cardiovascular research, stem cell biology, cardiac tissue engineering, and molecular pharmacology. Saleem's work leverages human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes to model cardiac diseases, study drug effects, and develop engineered heart tissues for translational applications. Key areas include genetic cardiomyopathies, SARS-CoV-2 cardiac complications, calcium handling abnormalities, and drug safety screening methodologies.

Analysis of publication trends reveals consistent focus on cardiac contractility mechanisms, electrophysiological properties of stem cell-derived cardiomyocytes, and validation of engineered heart tissue platforms. Research spans fundamental molecular mechanisms to applied drug screening applications, with emphasis on reproducibility and standardization across multicenter studies.

Collaborative work spans numerous international institutions, with significant contributions to developing standardized protocols for hiPSC-based cardiac research and establishing engineered heart tissues as reliable platforms for drug testing and disease modeling.

Current research involves advanced cardiac tissue engineering, investigation of viral cardiac damage mechanisms, and refinement of stem cell-based models for personalized medicine applications.